By HT Correspondent | Edited by Abhinav Sahay | PTI, Raipur
UPDATED ON JAN 10, 2021 08:08 AM IST
- Bharat Biotech obtained DCGI approval for section 3 scientific trials in 26,000 contributors in over 25 centres throughout India, based on the corporate web site
Get our every day e-newsletter in your inbox
Thanks for subscribing to our every day e-newsletter.